ScienceDex / Researcher record
Rodgers, Buel
- Aavogen, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $1,206,955 | 1 | #5,461 |
| 2018 | $660,235 | 1 | #13,377 |
| 2019 | $1 | 1 | #45,470 |
| 2021 | $134,809 | 1 | #40,811 |
| 2022 | $904,058 | 1 | #11,127 |
| 2023 | $1,113,710 | 2 | #8,875 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20171 record
- FY20181 record
- FY20191 record
- FY20211 record
- FY20221 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Rodgers, Buel as a PI. Multi-PI records show the full award amount for context.
- 5R44AG079825-02R44Contact PIPreclinical Development of a Novel Gene Therapeutic for Inclusion Body Myositis$973.6Kaward amount
- 1R43AR083297-01R43Contact PIDevelopment of optimized adeno-associated viral capsids for muscle gene therapy$140.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Rodgers, Buel as a PI.
FY2023 award administered by Aavogen, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardAavogen, Inc.
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #5461
- 2021$2M Cumulative Funding